Synthesis and initial evaluation of efficacy of olean-12-en-28-ol, 3 beta-pentacosanoate for the symptomatic treatment of multiple sclerosis
| dc.contributor.author | Sen, A. | |
| dc.contributor.author | Senol, H. | |
| dc.contributor.author | Acar, O. Ozgun | |
| dc.contributor.author | Kale, E. | |
| dc.contributor.author | Dag, A. | |
| dc.contributor.author | Topcu, G. | |
| dc.contributor.authorID | 0000-0002-8444-376X | en_US |
| dc.contributor.authorID | 0000-0002-8333-035X | en_US |
| dc.contributor.department | AGÜ, Yaşam ve Doğa Bilimleri Fakültesi, Moleküler Biyoloji ve Genetik Bölümü | en_US |
| dc.date.accessioned | 2021-03-24T07:32:55Z | |
| dc.date.available | 2021-03-24T07:32:55Z | |
| dc.date.issued | 2019 | en_US |
| dc.description | This work was supported by the Scientific and Technological Research Council of Turkey [TUBITAK-117S293]. | en_US |
| dc.description.abstract | Synthesis and initial evaluation of efficacy of olean-12-en-28-ol, 3 beta-pentacosanoate for the symptomatic treatment of multiple sclerosis | en_US |
| dc.description.sponsorship | Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) TUBITAK-117S293 | en_US |
| dc.identifier.endpage | 74 | en_US |
| dc.identifier.issn | 2211-5463 | |
| dc.identifier.startpage | 74 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12573/610 | |
| dc.identifier.volume | Volume: 9 Supplement: 1 Meeting Abstract: P-01-022 | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA | en_US |
| dc.relation.journal | FEBS OPEN BIO | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.relation.tubitak | TUBITAK-117S293 | |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Synthesis and initial evaluation of efficacy of olean-12-en-28-ol, 3 beta-pentacosanoate for the symptomatic treatment of multiple sclerosis | en_US |
| dc.title | Synthesis and initial evaluation of efficacy of olean-12-en-28-ol, 3 beta-pentacosanoate for the symptomatic treatment of multiple sclerosis | en_US |
| dc.type | conferenceObject | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.44 KB
- Format:
- Item-specific license agreed upon to submission
- Description: